Skip to content

Atazanavir: final phase III results published

Report of rare atazanavir-related liver side-effect published

Is paying for treatment affecting adherence in Africa?

HAART reduces HIV transmission by 53% in Taiwan

Tenofovir and efavirenz show promise as a two drug maintenance regimen

Once-daily regimens improve adherence and treatment satisfaction

Fewer pills means better adherence, says Spanish study

Botswana: more testing, but men still reluctant

Four days of Combivir reduces risk of nevirapine resistance from PMTCT treatment